1-11 of 11
Hans T. Eich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

Clinical Trials & Observations
Michael S. Binkley, M. Shahzad Rauf, Sarah A. Milgrom, Chelsea C. Pinnix, Richard Tsang, Michael Dickinson, Andrea K. Ng, Kenneth B. Roberts, Sarah Gao, Alex Balogh, Umberto Ricardi, Mario Levis, Carla Casulo, Michael Stolten, Lena Specht, John P. Plastaras, Christopher Wright, Christopher R. Kelsey, Jessica L. Brady, N. George Mikhaeel, Bradford S. Hoppe, Stephanie A. Terezakis, Marco Picardi, Roberta Della Pepa, Youlia Kirova, Saad Akhtar, Irfan Maghfoor, Julie L. Koenig, Christopher Jackson, Erin Song, Shuchi Sehgal, Ranjana H. Advani, Yasodha Natkunam, Louis S. Constine, Hans T. Eich, Andrew Wirth, Richard T. Hoppe
Journal: Blood
Blood (2020) 135 (26): 2365–2374.
https://doi.org/10.1182/blood.2019003877
Published: 2020
Includes: Supplemental data
Journal Articles

Definitive radiotherapy for localized follicular lymphoma staged by 18 F-FDG PET-CT: a collaborative study by ILROG

Clinical Trials & Observations
Jessica L. Brady, Michael S. Binkley, Carla Hajj, Monica Chelius, Karen Chau, Alex Balogh, Mario Levis, Andrea Riccardo Filippi, Michael Jones, Michael Mac Manus, Andrew Wirth, Masahiko Oguchi, Anders Krog Vistisen, Therese Youssef Andraos, Andrea K. Ng, Berthe M. P. Aleman, Seo Hee Choi, Youlia Kirova, Sara Hardy, Gabriele Reinartz, Hans T. Eich, Scott V. Bratman, Louis S. Constine, Chang-Ok Suh, Bouthaina Dabaja, Tarec C. El-Galaly, David C. Hodgson, Umberto Ricardi, Joachim Yahalom, Richard T. Hoppe, N. George Mikhaeel
Journal: Blood
Blood (2019) 133 (3): 237–245.
https://doi.org/10.1182/blood-2018-04-843540
Published: 2019
Includes: Supplemental data
Journal Articles

Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

Clinical Trials & Observations
Boris Böll, Henning Bredenfeld, Helen Görgen, Teresa Halbsguth, Hans T. Eich, Martin Soekler, Jana Markova, Ulrich Keller, Ullrich Graeven, Stephan Kremers, Michael Geissler, Guido Trenn, Michael Fuchs, Bastian von Tresckow, Dennis A. Eichenauer, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2011) 118 (24): 6292–6298.
https://doi.org/10.1182/blood-2011-07-368167
Published: 2011
Journal Articles

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

Andreas Engert, MD, Volker Diehl, MD, Emeritus, Annette Pluetschow, Hans T. Eich, Richard Herrmann, MD, Bernd Doerken, Lothar Kanz, MD, Richard Greil, Jana Markova, Michael Fuchs, Peter Borchmann, PD, Dr., Hans Konrad Mueller-Hermelink, Rolf Peter Mueller
Journal: Blood
Blood (2009) 114 (22): 716.
https://doi.org/10.1182/blood.V114.22.716.716
Published: 2009
Journal Articles

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Peter Borchmann, Volker Diehl, Helen Goergen, Horst Mueller, Rolf Peter Mueller, Hans T. Eich, Hans Konrad Mueller-Hermelink, Richard Herrmann, MD, Jana Markova, Anthony D. Ho, MD, PhD, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Engert, MD
Journal: Blood
Blood (2009) 114 (22): 717.
https://doi.org/10.1182/blood.V114.22.717.717
Published: 2009
Journal Articles

Hodgkin Lymphoma in Adolescents Treated with Adult Protocols: An Analysis From the German Hodgkin Study Group (GHSG).

Dennis A. Eichenauer, Henning Bredenfeld, Jeremy Franklin, Heinz Haverkamp, Horst Mueller, Hans T. Eich, Rolf-Peter Mueller, Michael Fuchs, Peter Borchmann, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2009) 114 (22): 719.
https://doi.org/10.1182/blood.V114.22.719.719
Published: 2009
Journal Articles

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Carsten Kobe, Markus Dietlein, Jeremy Franklin, Jana Markova, Andreas Lohri, Holger Amthauer, Susanne Klutmann, Wolfram H. Knapp, Josee M. Zijlstra, Andreas Bockisch, Matthias Weckesser, Reinhard Lorenz, Mathias Schreckenberger, Roland Bares, Hans T. Eich, Rolf-Peter Mueller, Michael Fuchs, Peter Borchmann, Harald Schicha, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2008) 112 (10): 3989–3994.
https://doi.org/10.1182/blood-2008-06-155820
Published: 2008
Journal Articles

Leucopenia during Treatment Is a Good Prognostic Risk Factor for Patients Undergoing Chemotherapy for Hodgkin’s Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG).

Beate Klimm, Thorsten Reineke, Heinz Haverkamp, Hans T. Eich, Karolin Behringer, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2005) 106 (11): 2674.
https://doi.org/10.1182/blood.V106.11.2674.2674
Published: 2005
Journal Articles

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Andreas Engert, Annette Pluetschow, Hans T. Eich, Richard Herrmann, Bernd Doerken, Lothar Kanz, Richard Greil, Jana Markova, Beate Pfistner, Andreas Josting, Konrad Mueller-Hermelink, Ralf P. Mueller, Volker Diehl
Journal: Blood
Blood (2005) 106 (11): 2673.
https://doi.org/10.1182/blood.V106.11.2673.2673
Published: 2005
Journal Articles

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Beate Klimm, MD, Thorsten Reineke, Heinz Haverkamp, Hans T. Eich, MD, Andreas Josting, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD
Journal: Blood
Blood (2004) 104 (11): 1313.
https://doi.org/10.1182/blood.V104.11.1313.1313
Published: 2004
Journal Articles

Elderly Patients with Early-Unfavorable Stage Hodgkin’s Disease (HD) Have a Poorer Outcome When Treated with Combined Modality Treatment and Extended Field Radiotherapy (EF): A Retrospective Analysis of the German Hodgkin Study Group.

Andreas Engert, MD, Heinz Haverkamp, Hans T. Eich, MD, Andreas Josting, MD, Beate Pfistner, Volker Diehl
Journal: Blood
Blood (2004) 104 (11): 1305.
https://doi.org/10.1182/blood.V104.11.1305.1305
Published: 2004